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Primary health care strategies for the prevention of end-stage
renal disease in Cuba. End-stage renal disease (ESRD) is a
major health problem in the world, including Cuba. There is an
increasing trend in both the incidence and prevalence of ESRD.
Global projections consistently show an increase of patients in
maintenance dialysis, and also an epidemic trend in diabetes
mellitus and hypertension, two diseases that are leading causes
of ESRD in most countries. A new paradigm is necessary to
handle this major health problem, such as a public health model
that integrates health promotion and disease prevention.
In 1996, the Ministry of Public Health of Cuba launched a
national program for the prevention of chronic renal failure
(CRF). The progressive implementation of this program follows
several steps: the analysis of the resources and health situation
in the country; epidemiological research to define the burden
of CRF; continuing education for nephrologists, family doctors,
and other health professionals; and reorientation of primary
health care toward increased nephrology services, intervention,
and surveillance.
The main outcomes of the program have been: a rational re-
distribution of nephrology services in corresponding health ar-
eas of primary health care; nephrologists being brought closer
to the community; an improvement in the knowledge and ability
of family doctors and nephrologists in the prevention of chronic
renal disease; an increase in the number of patients with CRF
(serum creatinine ≥ 133 lmol/L or ≥ 1.5 mg/dL, or a glomeru-
lar filtration rate < 60 mL/min) who are registered in primary
health care every year, from a prevalence of 0.59 per 1,000 in-
habitants at the beginning of the program in 1996 to 0.92 per
1,000 inhabitants in 2002, with a mean prevalence growth of
9.2% per year; a significant reduction (0.1%) in the incidence
of viral hepatitis B in dialysis patients after the implementation
of vaccination against viral hepatitis B in CRF patients who are
registered in primary health care; and the implementation of
CRF surveillance in primary health care, which provides peri-
odic information on CRF burden, patterns, and trends to assist
evidence-based public-health decision making, and measures
the impact of interventions in the population.
Primary health care is an essential tool, and the community
is an appropriate social space for health promotion and the
prevention of CRF and ESRD.
Key words: end-stage renal disease, preventive care, primary care,
chronic renal failure, health promotion, disease prevention.
C© 2005 by the International Society of Nephrology
Resumen
La insuficiencia renal cro´nica (IRC) es un problema de salud
pu´blica, tanto a nivel mundial como en Cuba. Existe una tenden-
cia hacia el aumento tanto en la incidencia como en la preva-
lencia de esta enfermedad. Las proyecciones a nivel mundial
estiman a futuro un incremento en el nu´mero de pacientes en
dia´lisis, ası´ como una tendencia epide´mica de la diabetes mel-
litus y la hipertensio´n arterial, las principales causas de IRC
en la mayorı´a de los paı´ses. Por lo anterior, se necesita de un
nuevo paradigma para enfrentar esta enfermedad; un modelo
de salud pu´blica donde se integren la promocio´n de la salud y
la prevencio´n.
En 1996, el Ministerio de Salud Pu´blica de Cuba inicio´ un
programa nacional para la prevencio´n de la IRC. La apli-
cacio´n del mismo se ha realizado en distintas etapas: determi-
nacio´n de la magnitud del problema, educacio´n continuada a
nefro´logos, me´dicos familiares y personal de salud, ası´ como
la reorientacio´n de los servicios nefrolo´gicos, de intervencio´n y
vigilancia, a los niveles primarios de salud.
Los principales logros de este programa han sido la redis-
tribucio´n de estos servicios a los niveles de atencio´n primaria,
el acercamiento de los nefro´logos a la comunidad y un mejor
conocimiento de la prevencio´n de la enfermedad renal entre
los me´dicos familiares y los nefro´logos. Tambie´n se ha obser-
vado un incremento anual en el numero de pacientes renales
cro´nicos (creatinina se´rica ≥133 lmol/L o ≥ 1.5 mg/dL, o una
velocidad de filtracio´n glomerular <60 mL/min)) registrados en
el nivel primario, de 0.59 por 1,000 habitantes al inicio del pro-
grama en 1996 a 0.92 por 1000 habitantes en el an˜o 2002, con
un promedio de crecimiento anual de la prevalencia del 9.2%.
La tasa de incidencia de la hepatitis B en pacientes en dia´lisis
ha disminuido dra´sticamente a un 0.1%, gracias a la vacunacio´n
de pacientes con insuficiencia renal registrados en este nivel. Fi-
nalmente, la vigilancia epidemiolo´gica ha permitido conocer la
magnitud de la IRC, sus patrones y tendencias, ası´ como el im-
plementar decisiones de salud pu´blica basadas en evidencias y
medir el impacto de intervenciones aplicadas en esta poblacio´n.
BACKGROUND
End-stage renal disease (ESRD) is a major health
problem in the world. There are increasing trends in
both the incidence and prevalence of ESRD. More
than 1,000,000 patients are receiving renal replacement
therapy (dialysis or renal transplantation) and more
than 220,000 new patients start dialysis every year [1].
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Global projections consistently anticipate an escalation
to 2,095,000 patients in maintenance dialysis and a pre-
dicted cost of approximately US $1.1 trillion through
2010 [2]. There is also an epidemic trend in diabetes
mellitus from 135,000,000 patients in 1995 to 300,000,000
projected patients by 2025 [3], and hypertension affects
approximately 1 billion individuals worldwide [4]. Both
diseases are leading causes of ESRD in the majority of
developed countries and in many developing countries.
Unfortunately, chronic renal disease (CRD) is both un-
derdiagnosed, because most of the patients are symptom
free, at least in the early stage of the disease, and under-
treated, because of late diagnosis and limited access to
dialysis in developing countries due to its prohibitive cost.
In addition to economic factors, there are also ethical, so-
cial, and political factors involved in the undertreatment
of CRD.
This reality emphasizes that the solution to this health
problem cannot be based on renal replacement therapy
only at the end stage of the disease. A new paradigm,
a public health model integrating health promotion and
disease prevention, is necessary. Taking these considera-
tions into account, the Ministry of Public Health of Cuba
launched the National Program for the Prevention of
Chronic Renal Failure in 1996 [5].
Purpose and aims of the program
There is evidence that CRD can be avoided or that pro-
gression to ESRD can be retarded, thus reducing the need
for renal replacement therapy. It is imperative that all
health care professionals and the communities they serve
be made aware of this health problem and actively partic-
ipate in its solution. In order for the prevention of CRD
and chronic renal failure (CRF) to be effective, health
promotion must be strengthened, patients and their fam-
ilies must be educated, active screening of at-risk persons
must be implemented, clinical interventions must be ini-
tiated, the quality of medical care must be enhanced, and
the active participation of the community must be se-
cured. The purpose of this program is to reduce the mor-
bidity and mortality of CRF in the population. Its main
goals are the prevention of risk factors for CRD in the
population, the early detection of patients with CRD or
CRF, avoidance or retardation of the progression of CRD
to ESRD, and improvement of patient quality of life.
Steps for implementing the national program
For the progressive implementation of the National
Program for the Prevention of Chronic Renal Failure,
several steps have been followed: analysis of resources
and health situation in the country; epidemiologic studies
of the frequency and distribution of CRD and CRF and
of the risk factors that contribute to the progression of the
disease; continuing medical education of family doctors,
nephrologists and other professionals; and the reorienta-
tion of nephrologic care in primary health care. Another
step has been the progressive implementation of preven-
tive actions regarding the basis of the program: health
promotion and lifestyle modification; identification and
screening of the at-risk population; rehabilitation and im-
provement of patient quality of life; and finally, the im-
plementation of a CRF surveillance system.
Resources and health situation in Cuba
The republic of Cuba is an archipelago composed of
the island of Cuba, the island of Youth, and more than
4195 rocky isles and small isles. Its geographic position is
at the entrance to the Gulf of Mexico in the Caribbean
Sea. The total area is 110,922 square kilometers. The total
population is 11,229,688 inhabitants. The official language
is Spanish.
There is a national health system in Cuba that is unique
in that it belongs to the state, with free access for the en-
tire population. There are 67,079 medical doctors, corre-
sponding to 1 medical doctor per 167 inhabitants, 31,059
of which are family doctors. The total population is cov-
ered by family doctors (primary health care) [6]. There is a
national nephrology net with a national coordination cen-
ter, the Institute of Nephrology. There are 33 nephrology
services with both hemodialysis and peritoneal dialysis
centers, 9 renal transplantation centers, 33 organ procure-
ment hospitals, and 263 nephrologists, which corresponds
to 1 nephrologist per 42,779 inhabitants [7].
Selected indicators show the health situation in the
country in 2002: the infant mortality rate was 6.5 per 1000
live born; 99.2% of children lived to be 5 years old; 95.0%
of children <2 years old had received complete vaccina-
tion against 13 preventable diseases; the life expectancy
was >75 years old; and only 1.0% of total deaths were
caused by infectious disease. The leading causes of death
were the following: non-communicable diseases (mortal-
ity rate per 100,000 inhabitants), including cardiovascular
disease (169.5), cancer (155.4), stroke (68.0), and diabetes
mellitus (12.8) [6]. This is the epidemiologic context in
which CRD is emerging in Cuba.
Epidemiologic studies: Burden of chronic renal failure
Several population-based epidemiologic studies have
been performed to define the morbidity, mortality, and
risk factors for CRF. A national mortality study of CRF,
based on medical death certificates, described a mortality
rate of 101 to 132 deaths per million population (PMP) in
1970 to 1972 [8]. This study was the basis for the planning
and distribution of nephrology services in the country.
Another national mortality study of multiple causes of
death from CRF, based on medical death certificates in
1991, identified these main causes of CRF: diabetes mel-
litus (30.5%), hypertension (19.8%), urologic conditions
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(9.8%), glomerulopathies (7.3%), and congenital CRF
(5.0%) [9].
For developing countries with limited access to dialysis
treatment, mortality studies may be a feasible way to de-
scribe the frequency and distribution of the disease in the
population. One study of a population sample in the Pinar
del Rio province described a prevalence of 3.5 patients
with serum creatinine ≥ 1.2 mg/dL per 1,000 inhabitants
[10]. Another study in the Camagu¨ey province described
a prevalence of 3.3 patients with serum creatinine ≥ 141
lmol/L per 1,000 inhabitants [11].
A population-based follow-up study of 627 patients in
the Cienfuegos province, who had CRF with a glomeru-
lar filtration rate (GFR) of <70 mL/min over 8 years [12],
described an increasing cumulative prevalence from 0.3
patients per 1000 inhabitants in 1984 to 1.1 per 1000 in-
habitants at the end of the study in 1991. The patients
had been diagnosed by screening into risk groups, mainly
those with diabetes and hypertension, and were followed
up with therapeutic intervention by nephrologists and
family doctors in primary health care. Also there were
changes in the distribution of the disease stages. At the
beginning of the study in 1984, the distribution of patients
according to GFR was: patients with a GFR of 70 to 50
mL/min (0%); 49 to 30 mL/min (37.6%); 29 to 10 mL/min
(48.6%) and <10 mL/min (12.8%). In 1991, 7 years later,
the distribution changed to 11.3%, 65.0%, 6.6%, and
17.1%, respectively. Due to early diagnosis and an ef-
fective therapeutic intervention in primary health care,
most patients were in the earliest stage of the disease.
In 2002, there were 1337 dialysis patients correspond-
ing to a prevalence of 119 PMP; 248 renal transplants
were performed, corresponding to 22 PMP; and 815 pa-
tients were alive with a functioning renal transplant in
Cuba [7].
Continuing medical education
The purpose of continuing medical education is to en-
hance the nephrologists’ and family doctors’ abilities to
provide care for patients with CRD in accordance with
the interventions of the program. For nephrologists, there
are courses in epidemiology and preventive nephrol-
ogy in the nephrology residency, as well as postgradu-
ate courses. For family doctors, there are a number of
educational opportunities: a 40-hour course in preven-
tion of CRF, available either through the policlinics with
the presence of a nephrology professor or through the
national health intranet information system; a residency
thesis for the Integral General Medicine Specialty (Fam-
ily Medicine) with a focus on the epidemiology of CRD;
and a 400-hour diploma in Preventive Nephrology in the
Community. Before the end of this year, guidelines of
actions for the prevention, diagnosis, and treatment of
CRD will be introduced in the health system.
Reorientation of nephrologic care in primary health care
A reorientation of nephrologic care in primary health
care is taking place. Its main goal is to bring nephrolo-
gists closer to the community. There are 33 nephrology
services and 444 policlinics (health areas), and each one of
the health areas has an average of 50 family doctors with
its corresponding regional office in primary health care.
The first step in reorientation was a rational territorial
redistribution of regional nephrology services, including
the dialysis center, which corresponded to the municipal-
ities and health areas in the whole country. The other step
was the organization of continuing joint management of
patients with CRF by family doctors and the correspond-
ing regional nephrologists in the policlinics.
Implementation of preventive actions: Strategy
As shown in Figure 1, health and disease are a part of a
continuous process, and the natural history of the disease
may be taken as a base for defining the strategies for CRD
prevention [13, 14]. A global strategy for the prevention
of CRD will be developed on the basis of the concept of
a chain, in which each chain link represents a population
group, either healthy (with increased behavior or biologi-
cal risks for CRD) or ill (in different stages of CRD). The
development of CRD is due to an interaction of several
factors: heredity, behavior, biological factors, and envi-
ronmental factors such as physical, economic, and social
factors that may influence the development of the disease.
There are 2 types of strategies for intervention that
are often complementary. One strategy focuses on the
whole population, with the aim of reducing average risk
(the population strategy). The other strategy focuses on
people at high risk as a result of particular exposures (the
high-risk individual strategy). The major advantage of the
population strategy is that it does not require identifica-
tion of high-risk groups, but its main disadvantage is that
it offers little benefit to individuals because the absolute
risk of disease is quite low. In the individual intervention,
it is necessary to identify at-risk persons to protect sus-
ceptible individuals, and so it is the most efficient strategy
for those at greatest risk [15].
Preventive actions are defined according to each pre-
vention level: primordial, primary, secondary, and tertiary
prevention. Health promotion involves health services,
industry, media, social organizations, and public health
policy. For the implementation of interventions, a bi-
ological, psychologic, and social approach is necessary,
along with individual, family, and community involve-
ment, as well as the reorientation of health services to
achieve the goals of the program. The challenge in avoid-
ing CRD, achieving its regression and remission, and
retarding its progression is to implement effective pre-
ventive actions in the population groups described in
each of the chain links. Carefully planned community
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Fig. 1. Strategies for the prevention of chronic renal disease.
programs are an important part of the overall effort to
solve the announced epidemic of CRD in this century.
There is a huge gap between our existing medical
knowledge and the dynamic changes in society. The ma-
jor causes of CRD (diabetes mellitus and hypertension)
are epidemic noncommunicable diseases, and the under-
lying cause of these epidemic diseases is an increase in
lifestyle-related risk factors, which result from cultural,
psychologic, economic, social, and political changes. The
aim of a community program is to help people and com-
munities overcome these obstacles to maintaining their
health.
This theoretic conception has been the basis of the
National Program for the Prevention of Chronic Renal
Failure (Fig. 2): health promotion and lifestyle modifica-
tion; identification and screening of the at-risk popula-
tion for CRD; registry, risk assessment, treatment, and
follow-up of patients with CRF in primary health care;
and rehabilitation and patient quality of life, with empha-
sis on participation of family doctors and nephrologists in
primary health care and active participation of the indi-
vidual, family, and community. The characteristics of the
national health system in Cuba facilitate the progressive
introduction of preventive actions in the general popula-
tion.
Health promotion and lifestyle modification
Health promotion is the process by which individu-
als and communities exert more control on the deter-
minants of health and, in this way, they improve their
health status. The program strengthens health promo-
tion in the population, in coordination with the national
government program for improving the quality of life
of the Cuban population. It is an educational program
promoting health education among the population, with
the goal of preventing the emergence and establishment
of those social, economic, and cultural patterns of living
that are known to contribute to an elevated risk for di-
abetes, cardiovascular disease, and progression of CRD.
Two national surveys [16] were conducted to evaluate the
impact of preventive actions in the lifestyle of the adult ur-
ban population. In 1995 and 2001, respectively, smoking
decreased from 36.8% to 33.2%, but despite the educa-
tional program, obesity increased from 32.0% to 42.3%
and physical inactivity increased from 33.2% to 43.5%.
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Fig. 2. National program for the prevention of CRF. Preventive actions.
Identification and screening of at-risk population for
CRD/CRF
The main risk groups defined in the program are pa-
tients with diabetes, patients with hypertension, children
with a history of low-birth weight, and the elderly (≥60
years old). The prevalence of known diabetics registered
by family doctors is increasing every year from 16.7 per
1000 inhabitants in 1993 to 27.1 per 1000 inhabitants in
2002. For patients with hypertension, the prevalence has
increased from 67.5 per 1000 inhabitants in 1993 to 177.5
per 1000 inhabitants in 2002. The low-birth-weight index
has decreased from 9.0% in 1993 to 5.9% in 2002 [7]. The
elderly population is increasing up to 13.8%, but a growth
of 16.9% and 21.0% in 2010 and 2025, respectively, is an-
ticipated.
Family doctors register these at-risk individuals and
must perform a medical risk assessment at least 3
times per year. Screening for proteinuria, microalbu-
minuria, serum creatinine, and glomerular filtration rate
(Cockcroft-Gault formula) depends on individual risk as-
sessment, and should be done every 1 to 3 years. A sur-
vey of a small group of 89 patients with diabetes for the
evaluation of preventive actions in primary health care
reported that they had received the following medical
tests within the last 12 months: blood pressure (97.8%),
blood glucose (95.5%), total cholesterol (58.2%), uri-
nalysis (74.2%), and serum creatinine (22.5%) [17]. The
low percentage of some biochemical tests, such as total
cholesterol and serum creatinine, corresponds to certain
financial limitations.
Registry, risk assessment, treatment, and follow-up of
patients with CRF
All patients diagnosed with CRF in any level of the
health system are referred to family doctors for registry
and follow-up. Confirmation of diagnosis, risk stratifi-
cation, and therapeutic planning must be completed by
nephrologists. All patients with a serum creatinine ≥133
lmol/L (≥1.5 mg/dL) or a GFR <60 mL/min must be
registered by the family doctor. Patient follow-up is con-
ducted jointly with nephrologists. As shown in Figure 3,
the prevalence of patients with CRF registered in primary
health care is increasing from 0.59 per 1000 inhabitants
at the beginning of the program in 1996, to 0.92 per 1000
inhabitants in 2002 [18]. The mean prevalence growth
of registered patients with CRF has been 9.2% every
year, from the inception of the program in 1997 to 2002,
in comparison with 1.6%, from 1995 to 1996 before the
program. The prevalence is higher among women (0.96
per 1000 inhabitants) compared with men (0.88 per 1000
inhabitants) (Fig. 4). The prevalence is highest among
the elderly: 3.76 per 1000 inhabitants in those aged 60
to 64 years, and 2.5 per 1000 inhabitants in those aged
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65 years or more. This trend has been increasing every
year (Fig. 5).
Regarding the prevention of viral hepatitis B (VHB)
in dialysis patients, there has been a significant reduc-
tion in incidence to 0.1% in 2002 due to the vaccination
of patients in the dialysis center beginning in 1992, and
the vaccination of all patients with serum creatinine ≥1.5
mg/dL beginning in 2000 [19].
Rehabilitation and improvement in patient quality of life
The purpose of patient rehabilitation is to improve
quality of life, reduce physical and psychologic limita-
tions and complications associated with CRF, and help
patients return to their families, jobs, and social lives. To
achieve this goal, the program recommends an individual
and integrated evaluation of patients’ physical aptitude,
psychologic state, nutrition, work, and social status by
a multidisciplinary staff that includes nephrologists, psy-
chologists, dieticians, and physical rehabilitators, accord-
ing to the stage of the disease. Patient evaluation may be
conducted in the hospital, but continuing rehabilitation
depends on the active participation of the patient and the
patient’s family and community.
Surveillance
All patients with CRF who are diagnosed by any spe-
cialist in the health system must be referred to their family
doctors. The family doctor working with the nephrolo-
gist must confirm the diagnosis. Risk stratification must
be completed by nephrologists. Family doctors register
patients in the medical record and in the daily medi-
cal record as a known patient (reconsultation), or as a
new patient in primary health care. The family doctor
must evaluate each patient with CRF at least 3 times
a year, depending on the patient’s risk assessment and
clinical condition. The family doctor makes the evalua-
tion of CRD and CRF in the community health situation
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Fig. 4. CRF patients registry in the primary health care.
analysis every year, and then performs the action plan.
This surveillance system provides information on the in-
cidence, prevalence, and distribution of patients (by gen-
der, age, and territory), as well as trends of CRF. Periodic
analysis of this information allows evidence-based public-
health decision-making and evaluation of the impact of
the interventions on the burden of CRF in the population.
CONCLUSION
Currently, this program is at a stage of progressive in-
troduction and implementation (extension) in Cuba. It
has achieved a rational reorientation of nephrologic care
in primary health care, along with the redistribution of
nephrology services in the corresponding municipalities
and health areas (policlinics in primary health care). Con-
tinuing education in preventive nephrology has been an
effective way to improve the knowledge and ability of
family doctors and nephrologists in the prevention of
CRD and CRF in primary health care. The number of re-
gistered patients with CRF in primary health care is in-
creasing every year. Vaccination against VHB in the early
stages of CRF has contributed to the reduction of VHB
in dialysis patients. The implementation of CRF surveil-
lance has been useful in providing periodic information
S-10 Almaguer et al: End-stage renal disease in Cuba
1993 1995 1997 1999 2001 2002
0
1
2
3
4
Pr
ev
a
le
nc
e 
×
 
10
00
 in
ha
bi
ta
nt
s
Years
< 1 5-9 10-14 15-24 25-59 60-64 > 641-4
Age groups (years old)
< 1 5-9 10-14 15-24 25-59 60-64 > 641-4
Prevalence × 1000 inhabitants
Age groups (years old)Years
1993
1995
1997
1999
2001
2002
0.04
0.02
0.01
0.01
0.07
0.04
0.10
0.06
0.06
0.04
0.21
0.19
0.13
0.13
0.14
0.07
0.31
0.29
0.11
0.13
0.16
0.15
0.34
0.33
0.16
0.21
0.32
0.25
0.40
0.41
0.38
0.61
0.55
0.62
0.76
0.81
1.46
2.22
2.90
3.36
3.71
3.36
0.99
1.61
1.75
1.95
2.26
2.50Fig. 5. Increasing prevalence of CRF patientsin the elderly population.
on CRF burden, patterns, and trends; decision making;
and measuring the impact of interventions in the popu-
lation. Primary health care is an essential tool, and the
community is an appropriate social space for health pro-
motion and prevention of CRD and ESRD.
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